Inhibition of HBV replication by EVA1A via enhancing cellular degradation of HBV components and its potential therapeutic application.
Yu J, Shen Z, Chen S, Liu H, Du Z, Mao R, Wang J, Zhang Y, Zhu H, Yang S, Li J, Wu J, Dong M, Zhu M, Huang Y, Li J, Yuan Z, Xie Y, Lu M, Zhang J.
Yu J, et al. Among authors: zhu h, zhu m.
Antiviral Res. 2023 Aug;216:105643. doi: 10.1016/j.antiviral.2023.105643. Epub 2023 May 24.
Antiviral Res. 2023.
PMID: 37236321